Clinical Trial Update: In-Office Study of the Hummingbird® in Children 6 Months-21 Years Old [NA]

View source ↗

Summary

Completed in-office study of the Hummingbird device in children ages 6 months to 21 years for ear infection/otitis media; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ear Infection
• Otitis Media

Drugs mentioned

• Hummingbird

Snippet

Sponsor: Preceptis Medical, Inc. | Conditions: Ear Infection, Otitis Media | NA | Status: COMPLETED | Results posted: 2022-12-14